Cahill Represents Danaher in Investment in BlueWhale Bio
Date: 09/07/23
Cahill advised Danaher Ventures LLC, the corporate venture subsidiary of Danaher Corporation, in its investment in BlueWhale Bio, Inc., a new company spun out of the University of Pennsylvania to overcome key bottlenecks in cell and gene therapy manufacturing. BlueWhale Bio raised $18 million in Seed financing, led by Danaher. BlueWhale Bio is the first company to emerge from the Danaher Ventures Pioneer Program, which creates companies in partnership with leading technology founders with the goal of developing and commercializing highly disruptive products and services to advance scientific research and improve lives on a global scale.
For more information, please click here.